4th Quarter - Report

TODD STRATEGY GROUP for EMD SERONO INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 16, 2022 $50,000 Replaced
4th Quarter - Report Jan 19, 2022 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare coverage and reimbursement.

LobbyistCovered position, as disclosed
PAUL EDATTEL —
DANIEL M TODD —
NICHOLAS UEHLECKE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Drug pricing policy. H.R.5376 - Build Back Better Act. H.R.3684 - Infrastructure Investment and Jobs Act.

LobbyistCovered position, as disclosed
PAUL EDATTEL Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ctr. - Medicare & Medicaid
NICHOLAS UEHLECKE Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3684 (117th), H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.